Metoprolol succinate and Postmenopausal haemorrhage - a phase IV clinical study of FDA data

Summary:

Postmenopausal haemorrhage is reported as a side effect among people who take Metoprolol succinate (metoprolol succinate), especially for people who are 60+ old, also take Norvasc, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Postmenopausal haemorrhage when taking Metoprolol succinate. It is created by eHealthMe based on reports of 64,247 people who have side effects when taking Metoprolol succinate from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Postmenopausal haemorrhage?

Postmenopausal haemorrhage (post-menopausal bleeding) is found to be associated with 380 drugs and 330 conditions by eHealthMe. Check the latest studies of Postmenopausal haemorrhage.

On Jul, 06, 2026

64,247 people reported to have side effects when taking Metoprolol succinate.
Among them, 11 people (0.02%) have Postmenopausal haemorrhage.

Could Metoprolol succinate cause Postmenopausal haemorrhage?

Among these 11 people:

What is the age of people who have Postmenopausal haemorrhage when taking Metoprolol succinate? *

What are other drugs people take besides Metoprolol succinate? *

What are other side effects people have besides Postmenopausal haemorrhage? *

Chest Pain: 3 people, 27.27%
High Blood Cholesterol: 3 people, 27.27%
Weakness: 3 people, 27.27%
Back Pain: 3 people, 27.27%
Cardiac Failure Congestive: 3 people, 27.27%
Weight Decreased: 2 people, 18.18%
Nosebleed (bleeding from nose): 2 people, 18.18%
Cervix Neoplasm (tumour of cervix): 2 people, 18.18%
Rales (an abnormal respiratory sound characterized by fine crackles): 2 people, 18.18%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 18.18%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 27.27%
High Blood Cholesterol: 2 people, 18.18%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 18.18%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 9.09%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
Menopause (end of monthly cycles in women): 1 person, 9.09%
Hot Flush (sudden feelings of heat): 1 person, 9.09%
Endometrial Cancer: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and have Postmenopausal haemorrhage?

- Check whether Postmenopausal haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol succinate:

Metoprolol succinate (66,933 reports)

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Postmenopausal haemorrhage:

Postmenopausal haemorrhage (380 drugs)

Browse all the conditions that are associated with Postmenopausal haemorrhage:

Postmenopausal haemorrhage (330 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Metoprolol succinate) and Metoprolol succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.